LAMISIL AT- terbinafine hydrochloride aerosol, spray

LAMISIL by

Drug Labeling and Warnings

LAMISIL by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]


Trademark Results [LAMISIL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LAMISIL
LAMISIL
85528483 4256554 Live/Registered
Novartis AG
2012-01-30
LAMISIL
LAMISIL
77394986 not registered Dead/Abandoned
Novartis AG
2008-02-12
LAMISIL
LAMISIL
73786484 1567931 Live/Registered
SANDOZ AG (SANDOZ LTD., SANDOZ S.A.)
1989-03-13
LAMISIL
LAMISIL
73769411 not registered Dead/Abandoned
SANDOZ PHARMACEUTICALS CORPORATION
1988-12-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.